XML 120 R81.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Income Taxes - Additional Information (Details) - USD ($) | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Income Tax Disclosure [Line Items] |  |  |
Capitalized research and development domestic expenses amortization period | 5 years |  |
Capitalized research and development foreign expenses amortization period | 15 years |  |
Change in valuation allowance | $ 45,500,000 | $ 2,000,000 |
Percentage of corporations stock owned by stockholders to determine ownership change | 5.00% |  |
Maximum threshold percentage increases over a three year period of corporations stock owned by stockholders for ownership change | 50.00% |  |
Income tax penalties or interest | $ 0 | 0 |
Unrecognized tax benefits | $ 9,578,000 | $ 3,450,000 | $ 0
Description of income tax examination | The Company’s federal and State tax returns for all years, 2015 through 2023, remain subject to examination by taxing authorities due to the tax attribute carryforwards. |  |
Domestic Tax Authority |  |  |
Income Tax Disclosure [Line Items] |  |  |
Net operating loss carryforwards | $ 51,200,000 |  |
State and Local Jurisdiction |  |  |
Income Tax Disclosure [Line Items] |  |  |
Net operating loss carryforwards | 74,800,000 |  |
Federal Orphan Drug Credit |  |  |
Income Tax Disclosure [Line Items] |  |  |
Tax credit carryforward amount | 24,800 |  |
Research Tax Credit Carryforward | Domestic Tax Authority |  |  |
Income Tax Disclosure [Line Items] |  |  |
Tax credit carryforward amount | 8,900,000 |  |
Research Tax Credit Carryforward | State and Local Jurisdiction |  |  |
Income Tax Disclosure [Line Items] |  |  |
Tax credit carryforward amount | $ 3,200,000 |  |
Tax credit carryforward expiration year | 2031 |  |
Minimum |  |  |
Income Tax Disclosure [Line Items] |  |  |
Income tax examination year under examination | 2015 |  |
Maximum |  |  |
Income Tax Disclosure [Line Items] |  |  |
Income tax examination year under examination | 2023 |  |

X
- Definition Capitalized research and development domestic expenses amortization period. + References No definition available. + Details
Name: | aclx_CapitalizedResearchAndDevelopmentDomesticExpensesAmortizationPeriod
Namespace Prefix: | aclx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Capitalized research and development foreign expenses amortization period. + References No definition available. + Details
Name: | aclx_CapitalizedResearchAndDevelopmentForeignExpensesAmortizationPeriod
Namespace Prefix: | aclx_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Income tax disclosure. + References No definition available. + Details
Name: | aclx_IncomeTaxDisclosureLineItems
Namespace Prefix: | aclx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum threshold percentage increases over a three year period of corporations stock owned by stockholders for ownership change. + References No definition available. + Details
Name: | aclx_MaximumThresholdPercentageIncreasesOverAThreeYearPeriodOfCorporationsStockOwnedByStockholdersForOwnershipChange
Namespace Prefix: | aclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of corporations stock owned by stockholders to determine ownership change. + References No definition available. + Details
Name: | aclx_PercentageOfCorporationsStockOwnedByStockholdersToDetermineOwnershipChange
Namespace Prefix: | aclx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tax credit carryforward expiration year. + References No definition available. + Details
Name: | aclx_TaxCreditCarryforwardExpirationYear
Namespace Prefix: | aclx_
Data Type: | xbrli:gYearItemType
Balance Type: | na
Period Type: | duration

X
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15 + Details
Name: | us-gaap_IncomeTaxExaminationDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15 + Details
Name: | us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Tax year being audited in the income tax examination, in YYYY format. + References No definition available. + Details
Name: | us-gaap_IncomeTaxExaminationYearUnderExamination
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:gYearListItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3 + Details
Name: | us-gaap_OperatingLossCarryforwards
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3 + Details
Name: | us-gaap_TaxCreditCarryforwardAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of unrecognized tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 217 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B + Details
Name: | us-gaap_UnrecognizedTaxBenefits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2 + Details
Name: | us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TaxCreditCarryforwardAxis=aclx_FederalOrphanDrugCreditMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |